Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc monthly Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-10.47 Insider Own0.10% Shs Outstand142.42M Perf Week-4.03%
Market Cap11.75B Forward P/E10.91 EPS next Y7.56 Insider Trans-9.31% Shs Float137.24M Perf Month-1.05%
Income-1502.50M PEG- EPS next Q1.66 Inst Own73.30% Short Float3.29% Perf Quarter-13.23%
Sales5.64B P/S2.08 EPS this Y-95.80% Inst Trans-2.41% Short Ratio2.47 Perf Half Y-16.45%
Book/sh60.52 P/B1.36 EPS next Y8.51% ROA- Target Price104.79 Perf Year-44.26%
Cash/sh- P/C- EPS next 5Y6.33% ROE- 52W Range79.59 - 151.47 Perf YTD-42.65%
Dividend0.58 P/FCF- EPS past 5Y-59.80% ROI0.60% 52W High-45.53% Beta0.71
Dividend %0.70% Quick Ratio1.10 Sales past 5Y0.10% Gross Margin38.20% 52W Low3.66% ATR2.64
Employees13242 Current Ratio1.70 Sales Q/Q0.80% Oper. Margin- RSI (14)39.73 Volatility2.23% 2.90%
OptionableYes Debt/Eq0.68 EPS Q/Q- Profit Margin- Rel Volume0.88 Prev Close81.95
ShortableYes LT Debt/Eq0.65 EarningsNov 10 BMO Payout- Avg Volume1.83M Price82.50
Recom2.80 SMA20-5.29% SMA50-6.05% SMA200-16.67% Volume1,613,326 Change0.67%
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Dec-08-16 12:56PM  ETFs with exposure to Perrigo Co. Plc : December 8, 2016
06:36AM  Perrigo Announces Portfolio Review Developments And Intention To Restructure Branded Consumer Healthcare's Belgium Business PR Newswire
Dec-01-16 10:12AM  Hedge Funds Are Buying Perrigo Company plc Ordinary Shares (PRGO) at Insider Monkey
Nov-29-16 11:05AM  What Do Analysts Have to Say about Mallinckrodt?
Nov-24-16 11:04AM  Patent Litigations to Delay Tevas New Product Launches
Nov-21-16 08:15AM  Post Earnings Coverage as Perrigo Q3 Results Beat Expectations Accesswire
Nov-19-16 01:40AM  [$$] Starboard Value Ponders Perrigo Assets at Barrons.com
Nov-17-16 11:00AM  NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe at Bloomberg
Nov-16-16 02:07AM  Jeffrey Smith's Starboard Value Discloses Major Stake in Perrigo (PRGO) at Investopedia
Nov-15-16 03:44PM  Starboard Value Out Of Darden (DRI), In On Perrigo (PRGO), HP (HPE) in a Big Way at Insider Monkey
10:04AM  Why Did Valeant Revise Its 2016 EPS Guidance?
07:39AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 15, 2016
Nov-14-16 02:13PM  ETFs with exposure to Perrigo Co. Plc : November 14, 2016
07:48AM  What did hedge funds trade in Q3?
Nov-11-16 09:47AM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
06:52AM  Perrigo upgraded by BofA/Merrill
Nov-10-16 04:06PM  Edited Transcript of PRGO earnings conference call or presentation 10-Nov-16 1:30pm GMT +6.71%
09:29AM  Stocks to Watch: Macy's, Hilton and Kohl's at The Wall Street Journal
08:42AM  Perrigo (PRGO) Beats on Q3 Earnings, Revenues; View Intact
08:36AM  [$$] Perrigo Considering Strategic Alternatives for MS Drug at The Wall Street Journal
07:57AM  Early movers: KSS, MET, COP, PRTY, BBY, CAS, SHAK, TWTR, MYL & more at CNBC
07:39AM  Perrigo to review options for Multiple Sclerosis drug Tysabri
07:38AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q3 2016 Perrigo Company PLC Earnings Release - Before Market Open
05:59AM  Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition
05:56AM  Perrigo reports 3Q loss
02:21AM  Perrigo to review options for multiple sclerosis drug royalties
01:50AM  Perrigo Company plc Reports Third Quarter 2016 Financial Results PR Newswire
01:48AM  Perrigo Company Plc to Review Strategic Alternatives for Tysabri® Royalty Stream PR Newswire
01:45AM  Perrigo Company plc Announces Appointment of Two New Independent Directors to Board PR Newswire
Nov-09-16 07:58AM  Medical Product Nov 10 Earnings Lineup: PRGO, GKOS, VIVO
05:27AM  [$$] Health-Care Stocks Emerge as Winners From Trump Vote at The Wall Street Journal
Nov-08-16 04:10PM  Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance
11:47AM  Valeant Shares are Destroyed After Disastrous Q3
08:44AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Nov-07-16 08:27AM  Perrigo (PRGO) Q3 Earnings: What's in Store for the Stock?
Nov-01-16 01:22PM  Jerome Dodson Comments on Perrigo
Oct-27-16 04:48PM  Starboard CEO on Perrigo, Macy's and Retail Investments
04:48PM  Starboard CEO on Perrigo, Macy's and Retail Investments at Bloomberg
03:27PM  Starboard CEO: We've Had a Good Dialogue With Perrigo
03:27PM  Starboard CEO: We've Had a Good Dialogue With Perrigo at Bloomberg
Oct-26-16 08:56AM  Perrigo Company plc to Release Third Quarter Calendar Year 2016 Results on November 10, 2016 PR Newswire
Oct-25-16 10:04AM  Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit
Oct-21-16 11:20AM  7 Blue-Chip Stocks That Are Due for a Turnaround at Kiplinger
Oct-19-16 01:32PM  ETFs with exposure to Perrigo Co. Plc : October 19, 2016
Oct-17-16 01:36PM  Jerome Dodson Goes 2 for 2 in 3rd Quarter
Oct-14-16 02:15PM  Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
Oct-10-16 08:39AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : October 10, 2016
Sep-27-16 06:10PM  Teva Is Well Positioned for New Trends in the US Generic Market
11:04AM  Tevas OTC Business Is Playing out to Be a Key Growth Driver
08:15AM  Perrigo Invests In Tarex® Patented Technology, As A Key Investment In The Fight Against Methamphetamine Drug Abuse PR Newswire
Sep-21-16 08:04AM  What Is the Upside Potential for Valeant?
Sep-20-16 11:04AM  How Will Valeants Profitability Pan Out over the Long Term?
10:20AM  Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say
10:04AM  Why Valeant Offers Volume-Based Discounts for These Drugs
Sep-19-16 02:03PM  Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors
Sep-16-16 05:48PM  Arbor and Purdue Seen as Likely Bidders for DepoMed
04:52PM  Perrigo explores sale of royalties of drug Tysabri: sources
03:39PM  Perrigo explores sale of royalties of drug Tysabri -sources
Sep-14-16 07:50PM  [$$] Governance Change Needed at Mylan at The Wall Street Journal
01:19PM  Is Starboard Butting in at Perrigo? at Investopedia
Sep-13-16 04:30PM  Perrigo Up as Starboard Reveals Stake, Changes Proposed
02:16PM  Making a Loss Look Like a Profit: Where Perrigo Led the S&P 500
12:58PM  Perrigo Activist Campaign Was Inevitable, Says Expert at The Wall Street Journal
10:14AM  Deutsche Bank Echoes Starboard's Sentiment: Perrigo Is Undervalued
10:10AM  Company News for September 13, 2016
09:55AM  Hedge Funds Issue Open Letters
12:41AM  Asian stocks advance after worries over Fed rate hike ease AP
12:28AM  PRESS DIGEST- New York Times business news - Sept 13 Reuters
12:10AM  [$$] A Fitter Perrigo Is in Activists Interest at The Wall Street Journal
Sep-12-16 06:37PM  [$$] Perrigo shares jump as activist Starboard's stake revealed at Financial Times +7.35%
05:40PM  Business Highlights AP
04:25PM  Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes
04:05PM  Promises, Promises: Perrigo Is Latest Company Haunted by Predictions at The Wall Street Journal
03:55PM  Activist Starboard demands rapid changes at Perrigo
03:16PM  7 Stocks Trading on Big Volume -- and What to Do With Them Now
02:39PM  Starboard buys stake in drugmaker Perrigo, wants shakeup
02:26PM  [$$] A Fitter Perrigo Is in Activists' Interest at The Wall Street Journal
01:16PM  Perrigo CEO Says Review Ongoing, Activist Starboard Takes Stake
12:58PM  Starboard Gives Perrigo Needed Urgency at Bloomberg
10:55AM  US STOCKS-Tech boost helps Wall St reverse course to trade higher
10:27AM  A.M. Funds Roundup: Calm Doesn't Always End in a Storm; What's In Your Growth and Value Index Funds? at Barrons.com
10:02AM  US STOCKS-Wall St opens lower as investors fret over Sept rate hike
09:54AM  The advances in fight against Zika
09:44AM  Perrigo Shares Spike After Starboard's Smith Urges Asset Sales
08:50AM  Morning Movers: PRGO, MYL, HPQ, MRO, RIG
08:10AM  Perrigo Acknowledges Receipt Of Letter From Starboard Value LP PR Newswire
08:04AM  Price Erosion Could Impact Perrigos Prescription Drug Business
08:04AM  Perrigo (PRGO) Stock Advances, Starboard Discloses 4.6% Stake
07:16AM  Starboard discloses 4.6 percent stake in Perrigo, seeks changes
07:02AM  Perrigo's stock surges after Starboard discloses stake at MarketWatch
06:49AM  Starboard Discloses 4.6% Ownership in Perrigo and Delivers Letter to the CEO and Board of Directors PR Newswire
12:31AM  [$$] Starboard Value Takes 4.6% Stake in Perrigo, Worth Nearly $600 Million at The Wall Street Journal
Sep-11-16 11:17PM  Perrigo Targeted by Activist Starboard With New 4.6% Stake at Bloomberg
11:17PM  Perrigo Targeted by Activist Investor Starboard With 4.6% Stake
11:00PM  [$$] Starboard Value Takes 4.6% Stake in Perrigo at The Wall Street Journal
Sep-09-16 04:04PM  PERRIGO CO PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:04PM  Whats Expected from the Branded Consumer Healthcare Segment?
03:04PM  Consumer Healthcare Segment Expects Revenue of $2.6 Billion in 2016
12:37PM  What Are Analysts Recommendations for Perrigo in 2016?
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM